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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A143length (ﬂ) FGF18 induces cartilage formation by increasing chondrocyte
proliferation, resulting in increased overall extracellular matrix (ECM)
production by chondrocytes. Our hypothesis is that matrix degradation
is initially needed during this process in order to expand the lacunae
and make room in the matrix for the new chondrocytes. The aim of this
study was to characterize the ECM changes occurring in response to
direct stimulation with Sprifermin, using biomarkers of cartilage for-
mation (Pro-C2), cartilage degradation with impaired repair capacity
(C2M, AGNx2) and reversible form cartilage degradation (AGNx1).
Methods: Full depth cartilage explants (FDCex), punched from bovine
articular cartilage, were cultured for 45 days in four separate culture
plates (P1-4). Initially, the FDCex were pre-incubated either with (P1,
P2) or without (P3, P4) oncostatin M (OSM)/TNF-a (5/10 ng/mL) for 7
days, to investigate how catabolic induction inﬂuences the response to
subsequent anabolic treatment. All FDCex plates then received the same
treatments but with either single (P1, P3) or weekly (P2, P4) admin-
istration. Treatments were Sprifermin (1, 10, 50, 100 or 500 ng/mL), full-
length (ﬂ) FGF18 (100 ng/mL), IGF-I (100 ng/mL) as positive controls for
cartilage formation, or placebo as negative control, in six replicates
each. Cell viability was measured using AlamarBlue at day 45. To eval-
uate ECM changes, four biomarkers of cartilage turnover were quanti-
ﬁed in supernatants from days 14, 21, 28, 35 and 42 using well-
described ELISAs; Pro-C2 reﬂecting formation of type II collagen, C2M
and AGNx2 reﬂecting matrix metalloproteinase (MMP)-mediated deg-
radation of type II collagen and aggrecan, respectively, and AGNx1
reﬂecting aggrecanase-mediated degradation of aggrecan. Mean values
and standard error of the mean (SEM) were reported. For each time-
point, signiﬁcance levels from the placebo were found using one-way
ANOVA assuming normal distribution. These are indicated by asterisks;
*P < 0.05, **P < 0.01.
Results: Only weekly administration had an effect on the cartilage
turnover biomarkers. When comparing to placebo, the anabolic bio-
marker Pro-C2 was dose-dependently increased by Sprifermin, a
response that reached statistical signiﬁcance for the 100 and 500 ng/mL
at several time points (P < 0.05) compared to the vehicle control (ﬁg.
1A). Pre-incubation of the FDCex with OSM/TNF-a led to a decreased
and delayed response in Pro-C2 (ﬁg. 1B), which was only statistically
signiﬁcant for the 500 ng/mL dose (P < 0.05). Pro-C2 was increased by
IGF-I (pos. control) at all time points. The catabolic biomarkers C2M and
AGNx2 were not affected by any of the treatment doses. On the con-
trary, AGNx1 was slightly increased by Sprifermin however, it did not
reach statistical signiﬁcance. Cell viability was increased by all treat-
ments in a dose-dependent manner. Generally, the effect of ﬂFGF18 was
similar to Sprifermin.
Conclusions: The data presented here indicate that Sprifermin induced
increased formation of articular cartilage type II collagen ex vivo. In
addition, responsiveness of the articular cartilage to Sprifermin was
inﬂuenced by the catabolic status of the tissue prior to treatment.
Generation of MMP-mediated cleavage fragments of type II collagen
and aggrecan were unchanged by Sprifermin, but generation of the
aggrecanase-mediated cleavage fragment of aggrecan was slightly but
not statistically increased. Although additional research is needed to
conﬁrm this observation, the slight increase in AGNX1 might suggest
that matrix degradation is needed for expansion of lacunae, which may
be needed to initiate the process of cartilage formation.
Figure 1. Type II collagen formation, Pro-C2. In two parallel experiments,
bovine FDCex were pre-incubated for 7 days with (B) or without (A) OSM/
TNF-alpha (5/10 ng/mL), and then cultured further 35 days with weekly
adddition of indicated treatments. Pro-C2 (Nordic Bioscience) released to
the supernatant was measured to reﬂect type II collagen formation. Val-
ues are means ± SEM of six replicate FDCex. One-way ANOVA was used to
compare each point with its respective placebo-treated group. Sig-
niﬁcance levels are indicated by asterisks; *P < 0.05, **P < 0.01.207
EFFECT OF SELF ASSEMBLED PEPTIDE-SUBSTANCE P ON
PROGRESSION OF OSTEOARTHRITIS
S. KIM y, Y. Jung z, J. Kim z, Y. Cho y, S. Kim y. y Samsung Med. Ctr., Seoul,
Republic of Korea; zKorea Institue of Sci. Technology, Seoul, Republic of
Korea
Purpose: Substance P (SP) is known as a neuropeptide to recruit
intrinsic stem cells and to ameliorate arthritis via suppression of the
catabolic pathway. Self assembled peptide (SAP) hydrogel has a function
of releasing a neuropeptide slowly and incorporating speciﬁc motifs
based on desired function. The purpose of this study is to ﬁnd that SAP-
SP complex would inhibit the catabolic pathway caused by the osteo-
arthritis and enhance the cartilage regeneration by the recruitment of
intrinsic mesenchymal stem cells.
Methods: A total of 70 female Sprague Dawley rats underwent surgical
procedure (anterior cruciate ligament resection and medial meniscec-
tomy) for the osteoarthritis model. Mesenchymal stem cells were
acquired from the bone marrow of additional 5 Sprague Dawley rats.
KLD-12 was used as the SAP hydrogels and they were conjugated with
diverse amount of SP (17.5 mg, 35 mg, 70 mg). Ten rats were used for the
evaluation of biotinylated SAP-SP disappearance. Fifty rats were divided
into 5 groups: SAP (n¼10), SAP-SP17.5 (n¼10), SAP-SP35 (n¼10), SAP-
SP70 (n¼10), SAP-SP-MSC (n¼10), and control (n¼10) groups. Total 2ml
of SAP, SAP conjugated with diverse amount of SP, and normal saline
were injected into the left knee joint in each group 3weeks postsurgery.
Histologic examination, immunoﬂuorescent staining and qRT-PCR
for caspase-8 and TIMP-1, TUNEL assay for the chondrocyte apop-
tosis, and micro-computed tomography were conducted 6 weeks
after injections. Cell markers for the recruitment of intrinsic mes-
enchymal stem cells (CD90 and CD105) were evaluated by the
immunoﬂuorescent analysis. Behavioral studies were done before, 3
weeks after, and 6 weeks after treatment.
Results: Biotinylated SAP-SP stayed within the knee joint till 6 weeks
after the injection.Modiﬁed mankin scoreswere signiﬁcantly lower in
SAP-SP17.5 and SAP-SP35 groups than control group (P¼0.011 and
0.013). Immunoﬂuorescent staining and gene expression of caspase-8
and TIMP was signiﬁcantly lower in SAP-SP17.5, SAP-SP35, and SAP-
SP70 groups than control group. Expression of CD90 and CD105 was
higher in SAP-SP17.5, SAP-SP35, and SAP70 groups than other groups.
TUNEL assay showed decrease of apoptosis in SAP-SP17.5 and SAP-SP35
groups. However, neither bone mineral density nor behavioral results
showed any signiﬁcant difference between groups.
Conclusions: Injection of SAP-SP hydrogels improved histologic
changes of osteoarthritis and this might be due to the recruitment of
intrinsic mesenchymal stem cells, inhibition of catabolic pathway
and anti-apoptotic effect.
208
AXIAL KNEE ALIGNMENT INFLUENCES THE REPAIR OF FOCAL
ARTICULAR CARTILAGE DEFECTS e A TRANSLATIONAL STUDY IN
SHEEP
L. Goebel y, P. Orth y, A. Müller z, U. Wolfram x, D. Zurakowski 4,
A. Ignatius ¶, A. Bücker z, D. Pape#, M. Cucchiarini y, H. Madry y. yCtr. of
Experimental Orthopaedics, Homburg, Germany; zDept. of Diagnostic and
Interventional Radiology, Homburg, Germany; x Inst. for Surgical
Technology & Biomechanics, Bern, Switzerland; kDept.s of Anesthesia
and Surgery, Boston, MA, USA; ¶ Inst. of Orthopaedic Res. and
Biomechanics, Ulm, Germany; #Dept. of Orthopaedic Surgery,
Luxembourg, Luxembourg
Purpose: Marrow stimulating techniques are excellent options to treat
small symptomatic cartilage defects. However, the effect of axial
alignment on the repair of focal (non-OA) articular cartilage defects
remains unknown. Here, we tested the hypothesis, that unloading of a
full-thickness cartilage defect in the weight-bearing area of the sheep
medial femoral condyle by valgisation high tibial osteotomy (HTO)
results in improved cartilage repair in a sheep stiﬂe joint compared to
increased loading as induced by varus osteotomy. We further
hypothesized that a standard valgus correction is superior to
overcorrection.
Methods: Adult merino sheep (n¼ 19; 66.6 ± 5.0 kg) received bilateral
standardized (rectangular, 4 x 8 mm) full-thickness cartilage defects
treated by subchondral drilling. Additionally, all right hind legs
received a medial biplanar osteotomy of the proximal tibia (3 groups):
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A144(a) closing wedge HTO (5.5 varus; range: 4.0 - 6.5; increased load; n
¼ 4), (b) opening wedge HTO (6.5 valgus; range: 2.0 - 9.5; standard
correction; n ¼ 10), (c) opening wedge HTO (11.5 valgus; range: 10.5 -
13.5; overcorrection; n¼ 5). A small stature TomoFix plate ﬁxator was
applied to stabilize the osteotomy. All left hind legs served as controls.
Animals were allowed full weight-bearing postoperatively. Six months
post operation, animals were sacriﬁced, and the cartilage defects were
evaluated by 9.4 Tesla high-ﬁeld MRI (mMR; modiﬁed 2D MOCART
score), macroscopic, micro-CT, immunohistochemical and histological
scoring as previously described. All animal experiments were con-
ducted under an Institution Animal Studies Committee approved
protocol. Data analysis was performed using SPSS Statistics (IBM,
Armonk, NY), using generalized estimating equations estimation. In
each case, an independence working correlation structure was com-
pared with a more general structure according to the Quasi-Likelihood
under Independence Model Criterion statistic. Data are given as mean
± standard deviation. P values < 0.05 were considered statistical
signiﬁcant.
Results: Macroscopic cartilage repair improved signiﬁcantly after val-
gus standard correction compared to the control (5.4 ± 3.9 vs. 8.5 ± 2.4;
1.6-fold; P ¼ 0.019), as well as color (1.2 ± 0.9 vs. 2.0 ± 0.8; 1.7-fold; P ¼
0.012), surface (1.2 ± 0.7 vs. 2.1 ± 0.8; 1.9-fold; P < 0.001) and defect ﬁll
(1.2 ± 0.8 vs. 2.0 ± 0.7; 1.7-fold; P ¼ 0.002). mMR-tomographic cartilage
repair was also signiﬁcantly better after valgus standard correction for
defect ﬁll (7.5 ± 2.4 vs. 4.2 ± 1.9; 1.8-fold; P < 0.001) and total points
(33.3 ± 15.0 vs. 22.8 ± 5.6; 1.5-fold; P ¼ 0.034). Signal intensity sig-
niﬁcantly improved for varus and valgus overcorrection (both 10.0 ± 0;
P ¼ 0.045) compared to the control group (8.2 ± 3.8) while the valgus
standard correction group performed best (11.0 ± 7.0; P > 0.05). In the
histological scoring of cartilage repair, valgus standard correction
resulted in signiﬁcant better defect ﬁll (1.7 ± 1.8 vs. 3.7 ± 0.5; 2.2-fold; P
< 0.001; Figure 1) and total points (20.3 ± 4.8 vs. 24.7± 2.9; 1.2-fold; P¼
0.011). Varus correction signiﬁcantly deteriorated cellular morphology
(4.9 ± 0.2 vs. 4.4 ± 0.7; 1.3-fold; P ¼ 0.016) and collagen type II
immunostaining (0 ± 0 vs. 1.3 ± 1.5; P < 0.001). mCT-analysis showed a
signiﬁcant decrease of bone volume density in the underlying sub-
chondral bone plate for varus (26.8 ± 19.0; 1.7-fold; P ¼ 0.046) and
valgus overcorrection (18.5 ± 22.2; 2.5-fold; P¼ 0.001) compared to the
control (45.1 ± 27.1). In the subarticular spongiosa , bone mineral
density of varus (888.9 ± 26.0; 1,1-fold; P < 0.001), valgus standard
(883.8 ± 42.4; 1.05-fold; P ¼ 0.007) and valgus overcorrection groups
(936.4 ± 47.4; 1.1-fold; P < 0.001) were signiﬁcantly increased com-
pared to the control (843.4 ± 36.5); as well as trabecular thickness for
varus (0.231 ± 0.027; 1.3-fold; P < 0.001) and valgus standard correction
(0.228 ± 0.047; 1.2-fold; P < 0.001) compared to the control (0.184 ±
0.033).
Figure 1. Histological appearance of articular cartilage repair at 6 months.
Sections are representative for the respective treatment group: a - control,
b d varus, c d valgus standard correction, d d valgus overcorrection.
Safranin O/Fast green staining, asterisks indicate integration zone, þ -
note a drill hole ﬁlled with cartilaginous repair tissue. Scale bar ¼ 1 mm.Conclusions: Valgus standard correction results in signiﬁcantly
improved cartilage repair in the medial femoral condyle compared to
the controls. Caution is warranted to avoid valgus overcorrection. These
preclinical results have important clinical implications, as they support
the concept of unloading a full-thickness cartilage defect in the weight-
bearing area of the medial femoral condyle in patients with varus
malalignment by valgisation HTO (for example in the case of failed
cartilage repair).
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SYNERGISTIC EFFECTS OF PROGRANULIN AND LOW INTENSITY
PULSED ULTRASOUND ON CHONDROCYTE DIFFERENTIATION,
MIGRATION AND METABOLISM
S.M. Uddin, B. Richbourgh, Y.-S. Yi, C. Liu. New York Univ. Med. Ctr.,
NewYork, NY, USA
Purpose: The objective of this study it to use a novel chondrogenic and
anti-inﬂammatory growth factor, progranulin (PGRN), with external
Low Intensity Pulsed Ultrasound (LIPUS) as biomechanical stimuli to i)
enhance migration, proliferation and anabolism of chondrocytes, ii)
inhibit TNFa and IL-1b induced inﬂammation and catabolism and iii)
understand the underlying mechanism for combined condroprotective
effects.
Methods: LIPUS stimulations were applied using an acoustic device,
Sonicator 740 (Mettler Electronics, Anaheim, CA) with a 10cm2 trans-
ducer (35mm diameter) with characteristic frequency of 1Mhz, pulse
duration of 200ms, with repetitive frequency of 100 Hz at an intensity of
30mW/cm2 for 20 min per day. LIPUS condroprotective effects were
analyzed by studying chondrogenesis, chondrocytes migration and
metabolism in presences of IL-1b. Furthermore, synergistic effects of
Progranulin and LIPUS were assessed by analyzing GAG content in
human cartilage explants in presence of catabolic cytokines (IL-1b and
TNFa).
Results: LIPUS induces chondrogenesis of C3H10T1/2 mesenchymal
stem cells: As shown in Fig. 1a, LIPUS signiﬁcantly enhances the
expressions of gene speciﬁc for chondrocyte differentiation, including
Sox9 and Col II in BMP-2 stimulated C3H10T1/2 Cells. Furthermore,
LIPUS stimulation was able to antagonize the inhibition of chondro-
genesis by IL-1b.
LIPUS stimulation enhances chondrocytes migration: Chondrocytes
migration was assessed through scratch assay. LIPUS stimulation
increased inﬁltration of the gap after 48 hours and nearly closed it after
72 hours. In contrast IL-1b almost completely abrogated the chon-
drocytes migration. LIPUS restored cell migration in IL-1b stimulated
chondrocytes. ImageJ analysis show signiﬁcant increase of cell inﬁl-
tration due to LIPUS stimulation and inhibited IL-1b induced cell
abrogation (Fig 1b).
Synergistic effects of PGRN and LIPUS stimulation on chondrocyte
metabolism: LIPUS increased expressions of Col II, Aggregcan and COMP
in human chondrocytes and signiﬁcantly reduced expressions of
catabolic enzymes MMP13 and ADAMTS5. Furthermore, LIPUS also
suppresses IL-1b induced expression of MMP13 and ADAMTS5.
LIPUS and PGRN together showed synergistic effects by increasing
expressions of Col II, Aggrecan and Comp by 5-6 folds (Fig 2a). Safranin
O staining of human cartilage ex-plants with most apparent GAG con-
tent in LIPUSþPGRN treated ex-plants. In contrast, IL-1b and TNF-a
showed apparent reduction in Safranin O Staining. LIPUS and PGRN
inhibited the catabolic effects of cytokines with most obvious effects in
LIPUSþPGRN treated samples (Fig 2b).
Conclusions: LIPUS alone can enhance chondrocyte differentiation in
mesenchymal stem cells and chondrocytes migration in the in vitro
assays. IL-1beta has been shown to reduce chondrocyte migration
and chondrogenesis in MSCs [1, 2], LIPUS stimulations in presence of
IL-1beta rescues chondrocytes migration and chondrogenesis. The
analysis of metabolism associated markers showed LIPUS enhances
anabolism and show chondro-protective effects against IL-1beta
induced catabolism. The combination of PGRN and LIPUS showed up
to 6 fold increase in anabolic markers and apparent increase in GAG
content of cartilage explants with apparent chondro-protective role
against IL-1beta and TNF-alpha. The combine treatment of LIPUS and
PGRN has therapeutic potential to slowing down cartilage degrada-
tion and enhancing matrix depiction in damage cartilage by
